KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dynavax Technologies (DVAX) EBIT: 2010-2025

Historic EBIT for Dynavax Technologies (DVAX) over the last 16 years, with Sep 2025 value amounting to $21.3 million.

  • Dynavax Technologies' EBIT rose 110.98% to $21.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.4 million, marking a year-over-year increase of 195.06%. This contributed to the annual value of -$4.1 million for FY2024, which is 88.87% up from last year.
  • According to the latest figures from Q3 2025, Dynavax Technologies' EBIT is $21.3 million, which was up 47.42% from $14.4 million recorded in Q2 2025.
  • Dynavax Technologies' 5-year EBIT high stood at $128.2 million for Q2 2022, and its period low was -$30.2 million during Q1 2023.
  • Over the past 3 years, Dynavax Technologies' median EBIT value was -$1.6 million (recorded in 2024), while the average stood at -$2.6 million.
  • As far as peak fluctuations go, Dynavax Technologies' EBIT skyrocketed by 1,298.03% in 2022, and later tumbled by 198.33% in 2023.
  • Over the past 5 years, Dynavax Technologies' EBIT (Quarterly) stood at $80.7 million in 2021, then fell by 21.78% to $63.1 million in 2022, then slumped by 113.45% to -$8.5 million in 2023, then surged by 80.78% to -$1.6 million in 2024, then soared by 110.98% to $21.3 million in 2025.
  • Its EBIT was $21.3 million in Q3 2025, compared to $14.4 million in Q2 2025 and -$23.6 million in Q1 2025.